Percutaneous radiological gastrostomy (PRG) has been shown to provide a similar success rate as percutaneous endoscopic gastrostomy (PEG), with potential benefits of increased patient convenience and decreased procedure times and equipment costs [1] [2] [3] . PRG is an especially viable option for nutrition support in patients with head and neck cancer who are symptomatic or prophylactically for anticipated dysphagia due to radiation therapy [4] [5] [6] .
Percutaneous radiological gastrostomy (PRG) has been shown to provide a similar success rate as percutaneous endoscopic gastrostomy (PEG), with potential benefits of increased patient convenience and decreased procedure times and equipment costs [1] [2] [3] . PRG is an especially viable option for nutrition support in patients with head and neck cancer who are symptomatic or prophylactically for anticipated dysphagia due to radiation therapy [4] [5] [6] .
PRG has traditionally been performed as an inpatient (IP) procedure with an overnight stay, similar to PEG. While the feasibility and efficacy of PEG have been investigated as an outpatient (OP) procedure [7] , to our knowledge the literature is limited for PRG. OP procedures are often preferred by the patients, and can lead to significant savings and decrease the financial burden on healthcare.
The purpose of this retrospective study was to investigate the success and complication rates of PRG as an OP procedure versus IP procedure in head and neck cancer patients. We hypothesized that PRG can be successfully performed in an OP setting with comparable success and complication rates to an IP setting. Specifically, the 15-day mortality, 15-day early complications, 6-month minor complications, and 6-month major complications were compared between the 2 settings.
Methodology

Study Design and Population
Following institutional research ethics board approvals, the electronic medical records of all head and neck cancer patients who underwent PRG from January 2010 to June 2013 were reviewed. In total, 50 OPs and 51 IPs underwent 101 gastrostomy procedures.
The OPs were transferred post procedure to the Outpatient Procedure Unit, where the medical or radiation oncology service physician assessed them. If approved by the caring physician, the patient was discharged home to return to the cancer centre the following morning. They were at that time assessed by the integrated cancer team (medical oncology, radiation oncology, and dietician). The IPs were admitted prior to the procedure and observed overnight following the procedure. The enteral feeds were started in consultation with a registered dietician the next day, if so required.
Previous to 2012, all PRGs in head and neck cancer patients were inserted as IPs. In early 2012, the practice at our hospital transitioned into a predominantly OP PRG insertion for head and neck cancer patients.
Data Collection
Demographical data including age, gender, diabetes status, symptomatic vs prophylactic status, type and stage of cancer were recorded. Symptomatic status refers to the indication for G-tube placement due to symptoms of dysphagia, whereas prophylactic status refers to the prophylactic placement of G-tube against possible dysphagia during the course of the radiation therapy. Procedure notes and clinic notes were reviewed in order to record any complications. Complications were categorized into minor or major, as described in Table 1 . Any complication necessitating procedural intervention was classified as major. Complications were further classified as early if they occurred within 15 days of the procedure.
Inclusion and Exclusion Criteria
Patients with head and neck cancer who underwent PRG were included in the study. Patients with prior gastrostomy tube insertion were excluded.
Operative Technique
All procedures were performed by 1 of 3 fellowship trained interventional radiologists.
The patient ingested 125 mL of Polibar plus barium solution (Bracco Imaging, Milan) 12 to 16 hours before the procedure. Alternatively, the barium solution was given via nasogastric tube. Preprocedure sonographic examination of the abdomen was performed for left liver edge localization. Gastric insufflation was achieved via an existing nasograstric tube or by advancing a 5-F KMP catheter (Cook Medical, Bloomington, IN) into the stomach under fluoroscopic guidance via nasal approach. The abdomen was prepped and draped in a sterile fashion. Local anesthesia was administered to the abdominal wall. Conscious sedation was administered using a combination of intravenous midazolam and fentanyl.
The access site was localized via fluoroscopic examination of the insufflated stomach. Depending on operator preference, 1 or 2 T-fastener gastropexy sutures (Cook Medical) were placed percutaneously to bring the anterior stomach wall into contact with the anterior abdominal wall. An 18-gauge needle was used to access the gastric lumen. Placement was confirmed with air aspiration and contrast injection. A 0.035 Amplatz guidewire (Boston Scientific, Natick, MA) was advanced through the needle into the stomach, the needle was withdrawn and the tract dilated. A 12-F Wills-Oglesby gastrostomy tube (Cook Medical) was advanced into the stomach over the wire and the wire was withdrawn. The pigtail locking mechanism was deployed and contrast was injected via the tube for final placement confirmation. Catheters were fixated to the skin with a Stat-Lock device (Bard Medical, Covington, GA). Prophylactic antibiotics were not administered.
For IPs, tubes were not used for 24 hours following placement. Physician assessment for signs of peritonitis was performed before initiation of G-tube feeds. For OP procedures, the patient recovered in a monitored area for 4-6 hours. One liter of normal saline was infused intravenously over 4 hours to ensure proper hydration. The patient was discharged home after physician examination and returned to hospital the following morning for repeat physician assessment before initiation of oral or G-tube feeds.
Statistical Analysis
All the data was inserted in Microsoft Excel (Microsoft Corporation, Redmond, WA). Statistical analysis was performed using SPSS software v13.0 (SPSS Inc., Chicago, IL). The statistical analysis was performed in consultation with a statistician with an expertise in clinical research. The correlation of the clinical and demographic variables was assessed with a chi-square test. Results were considered statistically significant if P .05.
Results
Patients
The patient characteristics are provided in Table 2 . There were 51 and 50 patients in the IP and OP groups, respectively. The mean ages in IP and OP groups were 66.0 AE 11.4 years and 61.3 AE 12.9 years, respectively (P ¼.053). Eight patients in the IP group and 5 patients in the OP group were previously diagnosed with diabetes. More patients in the IP group were symptomatic at the time of the procedure compared to OP group (31 in IP vs 15 in OP groups, P <.05). The most common stage of malignancy was IVa, with 60.4% and 66.0% of patients having stage IVa disease in IP and OP groups, respectively. The breakdown for the origin of the head and neck malignancies is provided in Table 3 . The most common primary malignancy was oropharyngeal cancer seen in 56.9% of IPs and 76% of the OP population.
Complications
The types and rates of the complications are presented in Table 4 . Overall, the total number of complications was The most common complication was tube dislodgement (5 in IP and 3 in OP). Two IPs and 1 OP had 2 minor complications each, increasing the total to 18 minor complications within 15 patients; 1 IP had 2 early complications, increasing the total to 11 complications in 10 patients. The 15-day mortality was comparable between the 2 groups with 1 patient death in both groups (P > .05). The patient in the IP group developed respiratory distress and leukocytosis on post-PRG day 1. A chest X-ray confirmed aspiration pneumonia with contrast visible in the lung parenchyma. He passed away on post-PRG day 20. The OP mortality was in a patient who presented to the hospital with abdominal pain following the initiation of feeds on post-PRG day 1. On exam, there were no signs of peritonitis. Given his intention for comfort measures, no investigations were performed to further elucidate the cause of the pain. The patient's abdominal pain resolved on post-PRG day 2 and he passed away shortly thereafter.
Discussion
PRG offers a safe and viable option for providing nutrition in head and neck cancer patients [4] [5] [6] . It may be performed in symptomatic patients or prophylactically in patients who are undergoing radiation therapy. It is performed as an IP procedure in many centres around the world. While the feasibility and safety of PEG in an OP setting has been shown previously [7] , the literature is limited for PRG.
In this study, we aimed to investigate the complication and success rates of PRG in an OP compared to an IP setting. While there haven't been studies comparing the PRG in OP and IP settings specifically, there have been studies that have reported the complication rates of the PRG in other contexts. Cantwell et al [5] investigated the efficacy of antibiotic prophylaxis in preventing post-procedural infection for PRG in OPs with head and neck cancer. They reported 10 minor complications in 8 patients (14%) with no major complications or mortality. Our study had 8 total complications in 7 patients, with 4 minor (8%) and 4 major complications (8%), and 1 mortality (2%).
Silas et al [2] compared the complications and outcomes of PRG and PEG in 370 patients. They reported an all-cause mortality rate of 3.1% in PRGs performed on a mix of IPs and OPs. The major complication rate was 2.1% and minor complication rate was 22.8%. The authors found that IP status correlated with lower number of early and late complications overall in the combined PRG and PEG groups [2] . This is in contrast to our study where we observed similar complication rates between the OP and IP groups. Our study was limited to the head and neck cancer patients, which may contribute to the difference in results between the 2 studies.
Ho et al [8] reported complication rates for PRG to be 5.9% for major complications and <1% for procedure-related mortality. Another review by Shin et al [9] reported an average rate of less than 8% for major complications and 5%-10% for minor complications for radiology percutaneous gastrostomy. Our complication rates of 8% for both major and minor complications in the OP group are therefore consistent with complication rates reported previously.
There were 2 mortalities in this study, 1 in each group. Given the retrospective nature of the study, it is difficult to differentiate between disease-related and procedure-related mortality. There were no autopsies and the causes of the mortalities were attributed to the underlying head and neck cancer.
The IP and OP groups have very similar demographics, and comorbidities. The OP group had a greater proportion of oropharyngeal cancer (76%) when compared to the IP group (56.9%), not statistically significant. Both groups had similar stages of cancer. We would expect the 2 groups to be clinically similar, as the attribution to OP or IP procedures was related to a change in hospital procedural policy over time, as opposed to overall clinical status. The availability of an OP PRG insertion program after 2012 was the major variable leading to OP tube insertion. The IP group was more likely to be symptomatic of dysphagia. At our institution, symptomatic patients can have their procedure performed more quickly as IPs. We believe this reason explains why the IP group was more symptomatic. Given the retrospective nature of the study, other nonmeasured variables were impossible to control. The major complication rate of the IP and OP groups were comparable (5.9 vs 8.0%). The minor complication rate for the IP group (27.5%) was significantly higher than the OP group (8.0%). Dysphagia may be a risk factor for complication of PRG insertion. Dysphagia could be related to aspiration pneumonia. Aspiration pneumonia is a known complication of PRG and has been attributed for mortalities in prior studies [9] [10] [11] [12] .
There are limitations to our study. It is a retrospective study and, hence, the parameters are not perfectly controlled according to the study design. It would be interesting to further break down the complications in to minor and major for both early and late time periods. Our study was too small to break down the complications based on the stage of disease, and it may be beneficial in a larger patient population to correlate the stage of the tumour with the complication rates and to assess which patients would benefit most from prophylactic procedure prior to onset of symptoms. In addition, there was no objective measure of the patients' clinical status in this study other than cancer stage and diabetes status. Further measures such as cognitive status would be useful in understanding the correlation between the intervention outcomes and clinical status.
OP and same-day protocols have been studied and successfully implemented in a number of invasive procedures. They are shown to be more or equally convenient and safe for the patients, while also being cost-effective for the healthcare system with shorter hospital stays and more appropriate resource utilisation [13, 14] . Our study suggests that PRG can be safely and effectively performed as an OP procedure with similar complication and success rates as an IP setting in head and neck cancer patients. Further randomized prospective trials will be necessary to guide the clinical practice.
